Scarborough Advisors’s Quest Diagnostics DGX Stock Holding History

Scarborough Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37	Closed	-$7.25K	–	279
2026 Q1	$7.25K	Hold	37	–	–	﹤0.01%	479
2025 Q4	$6.42K	Hold	37	–	–	﹤0.01%	294
2025 Q3	$7.05K	Hold	37	–	–	﹤0.01%	279
2025 Q2	$6.65K	Buy	+37	New	+$6.43K	﹤0.01%	268
2024 Q3	–	Sell	-46	Closed	-$6.24K	–	212
2024 Q2	$6.24K	Buy	46 +1	+2%	+$137	﹤0.01%	240
2024 Q1	$5.92K	Buy	45 +1	+2%	+$130	﹤0.01%	243
2023 Q4	$6.13K	Buy	+44	New	+$5.79K	﹤0.01%	450

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Scarborough Advisors's DGX Position: Q2 2026 in Review

Scarborough Advisors sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 37 shares — an estimated $7.25K sold.

Scarborough Advisors first reported a position in DGX in Q4 2023 and held it in 7 quarters. The position peaked at $7.25K in Q1 2026. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Scarborough Advisors reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
Scarborough Advisors sold 37 Quest Diagnostics shares in Q2 2026, an estimated $7.25K.
Scarborough Advisors first reported a position in Quest Diagnostics in Q4 2023 and held it in 7 quarters.
Scarborough Advisors's Quest Diagnostics position peaked at $7.25K in Q1 2026.
1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.